The Drug And Gene Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Drug And Gene Delivery Devices Market?
The Drug And Gene Delivery Devices Global Market Report 2025 shows that the market size has seen significant growth in recent years. Specifically, the market size will increase from $0.61 billion in 2024 to $0.67 billion in 2025. This indicates a compound annual growth rate (CAGR) of 9.0% in this period.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Drug And Gene Delivery Devices Industry?
The Drug And Gene Delivery Devices Global Market Report 2025 predicts that by 2029, the market size will grow to $0.93 billion, with a compound annual growth rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 Drug And Gene Delivery Devices Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Drug And Gene Delivery Devices Market?
The key drivers in the drug and gene delivery devices market are:
• Increasing incidence of chronic diseases
• Growing demand for personalized medicine
• Increased awareness and adoption of gene therapy
• Growing popularity of non-invasive and minimally invasive procedures
Global Market Segmentation: Identifying Major Drug And Gene Delivery Devices Industry Segments
The drug and gene delivery devicesmarket covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Pre-order the 2025 Drug And Gene Delivery Devices Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Drug And Gene Delivery Devices Market?
The key trends in the drug and gene delivery devices market are:
• The market is observing a surge in advancements in biotechnology and genetic engineering.
• Technological advancements in drug delivery systems are becoming more prevalent.
• There is increasing investment in research and development within the market.
• The development of novel delivery platforms and advancements in diagnostic technologies are emerging as significant trends.
Who Are the Top Competitors & Leading Players in the Drug And Gene Delivery Devices Market?
Major companies in the drug and gene delivery devices market are:
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• AstraZeneca plc
• Medtronic plc
• Amgen Inc.
• Moderna Inc.
• Biogen Inc.
• Sarepta Therapeutics Inc.
• SCIEX
• Halozyme Therapeutics Inc.
• ViiV Healthcare Limited
• Uniqure NV
• Cytokinetics Inc.
• Prothena Corporation plc
• Intellia Therapeutics Inc.
• Voyager Therapeutics Inc.
• sfm medical devices GmbH
• Inovio Pharmaceuticals Inc.
• GenSight Biologics S.A.
• CRISPR Therapeutics
Regional Dominance: Which Area Leads the Global Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2024
